Alkermes, Inc. (NASDAQ:ALKS)

investor research

Top Analyst Upgrades and Downgrades: Apollo Education, Ford, GM, Alkermes, Cognizant and More

The S&P 500 hit yet another new all-time high this week, but many investors remain worried about buying the top or getting caught in a sell-off. 24/7 Wall St. reviews ...
Read Full Story »
Samuel Beckett Bridge

Are Biotech Stocks Located in Ireland Top Buyout Candidates?

St. Patrick's Day may have come and gone for this year, but some of the biotechnology stocks that are domiciled in Ireland might just be getting ready for the party. ...
Read Full Story »
DNA

Ten Top Biotech Merger and Partnership Candidates

One of the ways the big pharmaceutical and biotechnology firms grow their business is through partnerships and acquisitions. That was never more in focus than Thursday when Pfizer lost its ...
Read Full Story »
biotech

Top Pharma and Biotech Stocks to Buy From Key Investor Conference

The Leerink Global Healthcare conference is in full swing, and the reports coming out highlight what some top analysts on Wall Street already suspected. The rich are getting richer. With ...
Read Full Story »
JPMorgan_logo

J.P. Morgan Top Biotechnology Stocks to Buy for 2014

Biotechnology was an incredible performer in 2013, outperforming the S&P 500 by a stunning 36%. The analysts at J.P. Morgan think that the huge outperformance may lessen but can stay ...
Read Full Story »
health care

Antipsychotic Drug Recall of Risperdal Consta by the Johnsons Over Mold

Johnson & Johnson (NYSE: JNJ) has been one of the great health care and consumer products survivors of our lifetimes. Even the latest round of over-the-counter quality control flaws did ...
Read Full Story »
health care

Top Stocks That May Move Big at Jefferies Global Healthcare Conference

Once again, the Wall Street conference calendar is heating up. Next week is the widely attended Jefferies Global Healthcare Conference in New York City. Following the success of last year’s ...
Read Full Story »
Wall St Bull statue

Top Analyst Upgrades and Stocks to Buy: Alkermes, Sonus Networks and More

Investors and traders are always on the hunt for new research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls each morning ...
Read Full Story »
Bull and Bear

Top Analyst Downgrades and Cautious Views from Wall Street

Investors are used to seeing many Buy ratings from Wall St. analysts, but they often overlook or do not see when these analysts give lists of stocks to sell or ...
Read Full Story »
biotech

Merrill Lynch Offers Four Key Biotech Drug Updates

Biotech pipeline news and biotech drug news continues to hit. A report from Bank of America/Merrill Lynch is highlighting four small-cap to mid-cap biotech stocks with positive prescription trends so far ...
Read Full Story »
health care

Years Later, MS Drug Ownership Consolidation — M&A Next?

Biogen Idec Inc. (NASDAQ: BIIB) may be a half decade or so late on this move, but as the saying goes "better late than never." The biotech and drug company is the ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades (ADTN, ALKS, CBS, CSCO, GLW, DCI, ERJ, INCY, JNPR, MJN, MDT, REGN, SAP, LUV, VVUS, YUM, ZLTQ)

These are some of the top analyst upgrades, downgrades and initiations seen so far from Wall St. research calls this Thursday: ADTRAN Inc. (NASDAQ: ADTN) cut to Sell at UBS but ...
Read Full Story »

Top Analyst Upgrades and Downgrades (ALKS, AVT, KMX, CTCT, CME, DK, EXPD, HBAN, MPC, MYL, P, PSX, RCL, SPR, STJ, TRV)

These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Friday. Alkermes PLC (NASDAQ: ALKS) raised to Outperform as Bull of the ...
Read Full Story »

Top Analyst Upgrades and Downgrades (ALKS, NLY, AAPL, APOL, CMA, COP, DB, DUK, HOG, INTC, LINE, POT, SDRL, STJ, VVUS, Z)

These are some of the top analyst upgrades, downgrades and initiations we have seen from Wall St. research calls this Thursday. Alkermes PLC (NASDAQ: ALKS) raised to Outperform with $24 ...
Read Full Story »

Elan’s Spin-Off Creates Buyout Hopes (ELN, BIIB, ALKS, PFE)

Elan Corporation, plc (NYSE: ELN) may be surging on news that it is going to spin off its drug research unit, but now there is something else to consider.  Elan could ...
Read Full Story »